Carlos Matute has been nominated as MC Member of the COST Programme action number CA21130

Prof. Carlos Matute has been nominated as MC Member of the COST Programme action number CA21130 about “P2X receptors as a therapeutic opportunity” (PRESTO), the other representative of Spain, together with Dr. Pablo Pelegrín (Murcia).

P2X receptors (P2XRs) are ATP-gated ion channels involved in intercellular communication with an established role in neurodegeneration, infection, inflammation, cancer growth, and progression. In vitro and in vivo evidence, generated mainly by leading Europe-based laboratories, shows that P2XRs might be an ideal pharmacological target in these diseases and many others.

P2X receptors as a therapeutic opportunity